Ginkgo Bioworks Holdings (DNA) Net Income Growth (1y) (2021 - 2026)
Ginkgo Bioworks Holdings (DNA) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | 63.48% |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn | 1,228.66% |
| 10 | Ginkgo Bioworks Holdings | 445.53 Mn | 301.67 Mn | 16.38 Mn | 14.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.63% |
| Dec 31, 2025 | 24.91% |
| Sep 30, 2025 | -43.18% |
| Jun 30, 2025 | 72.24% |
| Mar 31, 2025 | 95.39% |
| Dec 31, 2024 | 49.20% |
| Sep 30, 2024 | 81.38% |
| Jun 30, 2024 | -25.31% |
| Mar 31, 2024 | 19.06% |
| Dec 31, 2023 | -22.31% |
| Sep 30, 2023 | 54.80% |
| Jun 30, 2023 | 74.15% |
| Mar 31, 2023 | 65.41% |
| Dec 31, 2022 | 89.22% |
| Sep 30, 2022 | -554.39% |
| Jun 30, 2022 | -1,131.22% |
| Mar 31, 2022 | -692.47% |
| Dec 31, 2021 | -3,503.81% |
| Sep 30, 2021 | -291.97% |